Article

Information about the 2013 CMSC Annual Meeting

News and updates about the 2013 Annual Meeting of the Consortium of Multiple Sclerosis Centers.

2013 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) & the Fifth Cooperative Meeting with Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)

May 29 — June 1

Orland, FL

The 2013 Annual Meeting of the CMSC will be held at the Hilton Orland Hotel in Orlando, FL.

According to the CMSC, the 2013 Annual Meeting is “unique in bringing together all groups committed to improving the lives of people with MS,” and will provide “state-of-the-art information on the latest treatments, research, models of care, epidemiology, genetics, and much more.”

Among the learning objectives for attendees at this year’s meeting:

  • Identify key concepts of the immunologic and neuropathologic disease processes associated with multiple sclerosis.
  • Recognize that the pathophysiology of multiple sclerosis is affected by gender, ethnocultural origin, and environmental factors and tailor diagnosis and management appropriately
  • Appropriately utilize tools and strategies that facilitate patient assessment in order to differentiate between cognitive problems, depression, and related psychosocial issues.
  • Incorporate information obtained through appropriate assessments into therapeutic plans of care for each area of concern.
  • Analyze the complex mechanisms underlying the pathophysiology of multiple sclerosis in order to more appropriately initiate and sustain evidence-based therapeutic interventions.
  • Critically evaluate disease monitoring measures in order to facilitate effective therapeutic decision-making and outcome assessment.

Planning your meeting

Click here to register for the 2013 Annual Meeting of the CMSC.

The CMSC offers a PDF version of the 2013 annual meeting schedule and agenda.

Exhibit hall hours for the 2013 CMSC Annual Meeting:

Wednesday, May 29

5:30-8:00pm (Opening Reception)

Thursday, May 30

7:00-10:00am

12:00-3:00pm

5:00-8:30pm

Friday, May 31

7:00-10:00am

12:00-3:00pm

ACTRIMS poster session:

Saturday, June 1

12:00-2:00pm (authors will be present and available for questions)

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.